Cristin Hubbard sold $18k of BMRN
EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC. 273 shares at an average of $64.92, traded May 2, 2025, filed May 6, 2025.
Score components
- +15RoleOfficer
- 0Trade size$18k at market
- 0Share of holdings soldSold 0.8% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001048477-25-000053, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 30, 2025 | AGrant or award Common Stock10b5-1 | +273 | $54.14 | $15k | 32,973 | May 6, 2025 |
| May 2, 2025 | SOpen-market sale Common Stock10b5-1 | -273 | $64.92 | $18k | 32,700 | May 6, 2025 |
Related signals
Other insiders at BIOMARIN PHARMACEUTICAL INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | BMRNsell BIOMARIN PHARMACEUTICAL INC | George Eric Davis EVP, Chief Legal Officer | $1.2M 17,557 shares | -22% | |
| 60Notable | BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $997k 16,486 shares | -17% | |
| 65Notable | BIOMARIN PHARMACEUTICAL INC | George Eric Davis EVP, Chief Legal Officer | $1.6M 26,061 shares | -26% | |
| 51Moderate | BIOMARIN PHARMACEUTICAL INC | Gregory R Friberg EVP, Chief R&D Officer | $382k 6,326 shares | -14% | |
| 10Weak | BIOMARIN PHARMACEUTICAL INC | Erin Burkhart GVP, Chief Accounting Officer | $106k 1,786 shares | -11% | |
| 13Weak | BIOMARIN PHARMACEUTICAL INC | Erin Burkhart GVP, Chief Accounting Officer | $93k 1,295 shares | -7% | |
| 41Moderate | BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $501k 7,034 shares | -7% | |
| 12Weak | BIOMARIN PHARMACEUTICAL INC | Erin Burkhart GVP, Chief Accounting Officer | $92k 1,344 shares | -9% | |
| 30Weak | BMRNsell BIOMARIN PHARMACEUTICAL INC | Charles Greg Guyer EVP, Chief Technical Officer | $350k 5,278 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.